Evaluating the Impact of the Pneumococcal Conjugate Vaccine Introduction in Indonesia

Program Description: To conduct an evaluation before and two years after the introduction of the Pneumococcal conjugate vaccine (PCV) to study the direct and indirect impact of PCV introduction on vaccine-type pneumococcal carriage among healthy Indonesian children under five years of age.
Funding Partners:
  • Bill & Melinda Gates Foundation
Program Partners:
  • CDC's National Center for Immunization and Respiratory Diseases
Program Location:
  • Indonesia
Immunization
Infectious Disease
Vaccines